Ready, Set, #SOHO2024! Start day 1 off right with jumping into any 1 (or 2 or 3) of any of the 11 challenges.

✅ In the AUGMENT-101 trial led by Ibrahim Aldoss, MD, of City of Hope, revumenib monotherapy achieved high ORR and MRD negativity rates in patients with KMT2Ar acute leukemias. 📰 Read more: buff.ly/4cPoggK

Had a great time at Society of Hematologic Oncology (SOHO) #SOHO2024 presenting about challenging MPN scenarios! I also learned a ton about anemia-directed therapies in MF from Stephen Oh and JAK2m clonal hematopoiesis from Lachelle Dawn!

LIVE from #SOHO2024: Ching-Hon Pui, MD, of St. Jude, received the Emil J Freireich Distinguished Pioneer Award! "Dr. Pui is admired by many of us and is a hero to many of us," said session chair Hagop Kantarjian,MD. "He is very well known for his work in childhood ALL."

📸 #BehindTheScenes at #SOHO2024: John F. DiPersio Lab, of WashU Medicine/WUSM Department of Medicine, stops by for an interview! 🙌 Stay tuned for interviews and more conference coverage here: buff.ly/4cTomDS

📈 Presented at #SOHO2024: Luspatercept use in #MDS is associated with fewer patient visits and less resource use compared with ESAs. 📚 Read more about the abstract led by Brian Ball of City of Hope. ➡️ buff.ly/47cRFQQ

Happy #SOHO2024 Day 2! We're so excited for another day of sessions, interviews, and more! In between sessions, check out our conference coverage and stay tuned for more 😊 ➡️ buff.ly/4cTomDS

⭐ Coming up at #SOHO2024: The MPN session, chaired by Laura C. Michaelis of Medical College of Wisconsin, and John Mascarenhas, MD, of Icahn School of Medicine at Mount Sinai, begins at 10:10 a.m. CT with a talk titled "Optimizing Selection of Available JAK Inhibitors in MF" by Prithviraj Bose of MD Anderson Cancer Center.

Dr John Seymour giving Dr Michael Keating plenary award lecture at #SOHO24 Society of Hematologic Oncology (SOHO) First patient ever treated with venetoclax (previously called ABT-199) was in June 2011 in Australia with Dr Seymour. Amazing how this drug has changed the practice of leukemia care,

🏅 John Seymour, MBBS, FRACP, PhD, of Peter Mac Cancer Centre, received the Michael J. Keating Outstanding Achievement Award at #SOHO2024!

📝 A study presented at #SOHO2024 investigated the therapeutic benefit associated with immune checkpoint inhibitors for the treatment of #MDS. 📰 Read more about the study by vanthana bharathi of Saint Peter's HCS. ➡️ buff.ly/3z9Q2Xw